KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to 0.07.

  • Organon's Equity Ratio rose 7292.44% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year increase of 7292.44%. This contributed to the annual value of 0.04 for FY2024, which is 72060.43% up from last year.
  • As of Q3 2025, Organon's Equity Ratio stood at 0.07, which was up 7292.44% from 0.05 recorded in Q2 2025.
  • Organon's 5-year Equity Ratio high stood at 0.49 for Q1 2021, and its period low was 0.18 during Q2 2021.
  • Over the past 5 years, Organon's median Equity Ratio value was 0.05 (recorded in 2023), while the average stood at 0.02.
  • Per our database at Business Quant, Organon's Equity Ratio crashed by 12601.61% in 2021 and then skyrocketed by 92059.29% in 2025.
  • Quarter analysis of 5 years shows Organon's Equity Ratio stood at 0.14 in 2021, then soared by 42.33% to 0.08 in 2022, then skyrocketed by 92.87% to 0.01 in 2023, then skyrocketed by 720.6% to 0.04 in 2024, then skyrocketed by 85.56% to 0.07 in 2025.
  • Its Equity Ratio stands at 0.07 for Q3 2025, versus 0.05 for Q2 2025 and 0.04 for Q1 2025.